<DOC>
	<DOCNO>NCT01956916</DOCNO>
	<brief_summary>Cystic fibrosis ( CF ) complex systemic disease mainly involve respiratory gastrointestinal ( GI ) tracts . The polymicrobial community composition respiratory GI tracts influence genetic environmental factor . Children CF may harbor abnormal intestinal microflora , alter cystic fibrosis transmembrane conductance regulator ( CFTR ) function heavy drug load ( antibiotic , pancreatic enzyme acid suppressor ) . The investigator previously demonstrate intestinal inflammation highly frequent CF child , major feature intestinal involvement . In addition , specific probiotic significantly improve airway GI inflammation preliminary trial . The investigator aim characterize intestinal respiratory microflora CF patient investigate effect daily Lactobacillus GG ( LGG ) supplementation GI airway microflora eventual relationship probiotic assumption clinical inflammation marker . The investigator aim eventually improve quality life CF patient , often suffer intestinal respiratory progressive disease , non invasive intervention consist supplementation probiotic bacteria .</brief_summary>
	<brief_title>Probiotics Cystic Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Cystic Fibrosis</mesh_term>
	<criteria>1 . A confirmed diagnosis CF document sweat chloride test 60 mmol/L confirm genotype analysis presence F508del/F508del F508del/other 2 . Boys girls 2 16 year age 3 . Clinical stability enrolment , define clinical evidence acute exacerbation , modification therapeutic regimen hospitalization last 2 week 4 . Pancreatic insufficiency 5 . Basal Forced Expiratory Volume 1 second 50 % predict value 1 . Colonization respiratory tract Burkholderia cepacia spp . 2 . Steroid therapy within one month enrolment 3 . Pregnancy fertile woman take oral contraceptive 4 . Parenteral oral antibiotic therapy within 2 week enrolment 5 . Regular assumption probiotic 6 . Regular assumption azythromycin</criteria>
	<gender>All</gender>
	<minimum_age>2 Years</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>September 2015</verification_date>
	<keyword>Pulmonary exacerbation</keyword>
	<keyword>Inflammation</keyword>
	<keyword>Intestinal microbiota</keyword>
</DOC>